Dabur Pharma Ltd has informed that the members of the Company will consider to approve by way of Postal Ballot the Special Resolution relating to change the name of the Company from Dabur Pharma Ltd to Fresenius Kabi Oncology Ltd, subject to approval of Central Government.The Company has appointed Mr. Kiran Sharma, Practicing Company Secretary as the Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner.
The Postal Ballot form duly completed should reach the scrutinizer not later than the closing of business hours on January 02, 2009. Dr. Satihs B Kulkarni, Managing Director an CEO and in his absence by any persons authorised by him shall announce the results of postal ballot on January 05, 2009.
The Postal Ballot form duly completed should reach the scrutinizer not later than the closing of business hours on January 02, 2009. Dr. Satihs B Kulkarni, Managing Director an CEO and in his absence by any persons authorised by him shall announce the results of postal ballot on January 05, 2009.
No comments:
Post a Comment